Melbourne based scientists have just published a study finding activin B is a biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (MECFS) using the Canadian Consensus Criteria.
March 2015 has been a busy month for biomarker discoveries for patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: two new papers published and one patent registered.
by Sasha Nimmo Australian scientists announce they have made a breakthrough in chronic fatigue syndrome testing, now looking for partners to bring a diagnostic test to market. An ABC radio interview with Australian scientists at Queensland’s Griffith University reveals they have identified new markers on white blood cells which can be used to screen chronic fatigue syndrome patients. … Continue reading Griffith Uni patents chronic fatigue syndrome diagnostic blood test